Olema Pharmaceuticals (OLMA) Other Non Operating Income (2020 - 2026)
Olema Pharmaceuticals (OLMA) reported Other Non Operating Income of $121000.0 for Q1 2026, up 402.5% year-over-year from $24079.6 in Q1 2025, and up 830.77% quarter-over-quarter from $13000.0 in Q4 2025.
Olema Pharmaceuticals (OLMA) Other Non Operating Income (2020 - 2026) Analysis & Trends
Olema Pharmaceuticals (OLMA) has 7 years of Other Non Operating Income data on file, last reported at $121000.0 in Q1 2026.
- Other Non Operating Income for Q1 2026 came in at $121000.0, up 402.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $184000.0 (up 308.89% YoY), and the FY2025 annual result was $23000.0, down 77.45% from the prior year.
- Other Non Operating Income rose to $121000.0 in Q1 2026 per OLMA's latest filing, from $13000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $138000.0 in Q3 2024 and troughed at -$120000.0 in Q3 2022.
- A 5-year average of $11764.7 and a median of $13000.0 in 2025 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2022 and 2025: Other Non Operating Income surged 2100.0% in 2022, then sank 335.29% in 2025.
- A 5-year view of Other Non Operating Income shows it stood at $67000.0 in 2022, then jumped by 38.81% to $93000.0 in 2023, then sank by 200.0% to -$93000.0 in 2024, then surged by 113.98% to $13000.0 in 2025, then surged by 830.77% to $121000.0 in 2026.
- Business Quant data shows OLMA's Other Non Operating Income at $121000.0 in Q1 2026, $13000.0 in Q4 2025, and $12000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Olema Pharmaceuticals | 1.08 Bn | 1.08 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 121,000.00 |
| Dec 31, 2025 | 13,000.00 |
| Sep 30, 2025 | 12,000.00 |
| Jun 30, 2025 | 38,000.00 |
| Mar 31, 2025 | -40,000.00 |
| Dec 31, 2024 | -93,000.00 |
| Sep 30, 2024 | 138,000.00 |
| Jun 30, 2024 | 40,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Dec 31, 2023 | 93,000.00 |
| Sep 30, 2023 | -79,000.00 |
| Jun 30, 2023 | -44,000.00 |
| Mar 31, 2023 | 11,000.00 |
| Dec 31, 2022 | 67,000.00 |
| Sep 30, 2022 | -120,000.00 |
| Jun 30, 2022 | 20,000.00 |
| Mar 31, 2022 | 6,000.00 |
| Dec 31, 2021 | 10,000.00 |
| Sep 30, 2021 | -56,000.00 |
| Jun 30, 2021 | -1,000.00 |